
Please try another search
Gland Pharma Limited engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally. It engages in research and development of pharmaceutical active pharmaceutical ingredient products, including synthesis of complex drug molecules, such as low molecular weight heparins, corticosteroids, peptides, and cytotoxic molecules. The company also offers its products for various therapeutic categories, such as anti- diabetic, anti-malarial, anti-infectives, anti-neoplastic, blood related, cardiac, gastro-intestinal, gynaecological, hormones, neuro/Cns, ophthal/otological, and other areas, as well as pain/analgesics, respiratory and pulmonology, and vitamins, minerals, and nutrients. In addition, it provides contract development, dossier compilation, technology transfer services. The company was incorporated in 1978 and is based in Hyderabad, India. Gland Pharma Limited operates as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Name | Age | Since | Title |
---|---|---|---|
Xiaohui Guan | 52 | - | Non-Executive Director |
Yifang Wu | - | - | Non-Executive Director |
Satyanarayana Murthy Chavali | 57 | 2018 | Independent Director |
Naina Lal Kidwai | 67 | 2021 | Independent Director |
Udo Johannes Vetter | 70 | 2018 | Independent Director |
Jia Ai Zhang | 63 | 2021 | Non-Independent Non Executive Director |
Essaji Goolam Vahanvati | - | 2020 | Independent Director |
Wenjie Zhang | 57 | 2024 | Non-Executive and Non-Independent Director |
Wei Huang | - | 2024 | Non-Executive Non-Independent Director |
Srinivas Sadu | 56 | 2011 | Executive Chairman |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review